Drug Type Biosimilar, Monoclonal antibody |
Synonyms Denosumab Biosimilar (Alvogen Korea Holdings Ltd.), 地舒单抗生物类似药(Alvogen Korea Holdings Ltd.), Ducogeva + [4] |
Target |
Action inhibitors |
Mechanism RANKL inhibitors(Tumor necrosis factor ligand superfamily member 11 inhibitors) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Active Organization- |
Inactive Organization- |
License Organization- |
Drug Highest Phase- |
First Approval Date- |
Regulation- |


| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D03684 | Denosumab biosimilar(Alvogen) |






